BioClinica Names Mukhtar Ahmed as eClinical President
News Apr 24, 2015
BioClinica®, Inc. has announced that Mukhtar Ahmed, a recognized business leader within the life sciences, healthcare and technology sectors, will join BioClinica on April 20th as President of its Global eClinical Business Unit.
Mr. Ahmed most recently served as Global Vice President at Oracle Corporation responsible for growing Global Consulting Services and leading the Life Sciences business toward transformative cloud platforms, big data solutions and digital medicine. During a career spanning more than 25 years in the healthcare research industry, Mr. Ahmed has held senior executive positions with multinational Contract Research Organizations and clinical informatics companies including Kendle, Parexel and Medidata.
"Mukhtar has an exemplary track record delivering significant business benefits and operational growth strategies within the clinical technology sector," BioClinica CEO John Hubbard said. "He has a deep understanding of our business and eClinical customers, making him the right leader to drive new levels of innovation and value in clinical development."
"BioClinica is an industry leader with a comprehensive product platform and technology-enabled services, and I look forward to expanding on this success," Ahmed said. "I'm honored and excited to take on a new role with an organization that has built a reputation for innovation and customer focus."
Mr. Ahmed is an industry advisor to a number of start-ups and mid-range private equity companies and is currently a board advisor for a European laboratory company. He has previously held board-level, non-executive posts with National Health Service primary care and strategic health trusts in the United Kingdom.
Mr. Ahmed is routinely an industry speaker on topics including scientific innovation, strategic outsourcing, business change management, and medical device and clinical technologies. He earned degrees including a B.S. in Applied Systems and an M.S. in Neurological Imaging from Brunel University, as well as an MBA and post graduate diploma in Computer Science from Buckinghamshire University College.
BioClinica will host its annual Trial Blazers Customer Conference in the Orlando, Florida area on May 5 and 6.
Antimalarial Drugs Could Offer Clinical Benefit to Cancer PatientsNews
Antimalarial drugs chloroquine and hydroxychloroquine could find another use as cancer treatments, according to a new clinical study published in ecancermedicalscience.READ MORE
Chemists Design More Efficient Microreactor Using 3D PrintingNews
Researchers developed an electrochemical microreactor using additive manufacturing technology (commonly known as 3D printing). The newly developed microreactor was tested on synthesis of isoindolinones, which are found in many natural products, pharmaceuticals, and biologically active molecules.READ MORE
Advanced Prostate Cancer: EMA Approves Abiraterone Combined With Hormone Therapy as First-line TreatmentNews
The prostate cancer drug abiraterone has been approved by the European Medicines Agency in combination with standard hormone therapy for use as a first-line treatment for advanced prostate cancer.READ MORE